LLY compared with MDGL: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

MDGLMadrigal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

MDGLMadrigal Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MDGL: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only MDGL 8

PFEPfizersupplier

—Gregory Pharmaceutical Holdings, Inc. (d/b/a UPM Pharmaceuticals)unlistedsupplier

—Rocheunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Cowen

unlistedsupplier

4 more · MDGL chain ›

Price

rebased to 0%

LLY, solidMDGL, dashed

LLYELI Lilly & Co

1,407.25· pre 1,416.42· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

MDGLMadrigal Pharmaceuticals, Inc.

396.06· pre 398.30· delayed

Pre-marketNov 3 '26delayed

Mkt cap$10.0BRevenue$431MQ3 FY26Revenue$958MFY25

Compare

Pre-marketNov 3 '26delayed

LLYELI Lilly & Co

MDGLMadrigal Pharmaceuticals, Inc.

1,407.25pre 1,416.42delayed

Price

396.06pre 398.30delayed

$1.3T

Mkt cap

$10.0B

Q3 FY26$24.4B

Revenue

$431MQ3 FY26

FY25$65.2B

Revenue

$958MFY25

LLY1,407.25vsMDGL396.06Pre-marketNov 3 '26delayed